|
JPS60235136A
(ja)
*
|
1984-05-09 |
1985-11-21 |
Kyodo Printing Co Ltd |
検版方法
|
|
US4709914A
(en)
*
|
1985-02-07 |
1987-12-01 |
Brandt, Inc. |
Electronic controller for dispensers and the like
|
|
JPH0694317B2
(ja)
*
|
1987-01-27 |
1994-11-24 |
富士電機株式会社 |
被搬送体検知装置
|
|
GB8704269D0
(en)
*
|
1987-02-24 |
1987-04-01 |
Rue Systems De |
Monitoring system
|
|
JPH0614384B2
(ja)
*
|
1987-04-13 |
1994-02-23 |
ローレルバンクマシン株式会社 |
紙幣判別装置
|
|
US4958307A
(en)
*
|
1987-11-20 |
1990-09-18 |
Kabushiki Kaisha Toshiba |
Roll mark inspection apparatus
|
|
US4951223A
(en)
*
|
1989-03-28 |
1990-08-21 |
Langdon Wales R |
Web material inspection system
|
|
JPH0757127A
(ja)
*
|
1992-06-01 |
1995-03-03 |
Sayama Precision Ind Co |
光補正機能を有する紙幣等の識別機
|
|
GB2284293B
(en)
*
|
1993-11-30 |
1998-06-03 |
Mars Inc |
Article classifying method and apparatus
|
|
US5807552A
(en)
*
|
1995-08-04 |
1998-09-15 |
Board Of Regents, The University Of Texas System |
Compositions for conferring immunogenicity to a substance and uses thereof
|
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
|
CN1230444C
(zh)
*
|
1998-11-16 |
2005-12-07 |
德克萨斯州立大学董事会 |
含有hiv细胞毒t淋巴细胞表位的hiv多肽或肽或其多聚核苷酸表达构建体的用途
|
|
WO2001026357A1
(en)
*
|
1999-10-06 |
2001-04-12 |
Omron Corporation |
Recognition apparatus
|
|
KR20080017471A
(ko)
*
|
2000-02-21 |
2008-02-26 |
파멕사 에이/에스 |
아밀로이드의 하향-조절을 위한 신규한 방법
|
|
DK1259251T3
(da)
*
|
2000-02-21 |
2006-03-06 |
Pharmexa As |
Hidtil ukendt fremgangsmåde til nedregulering af amyloid
|
|
US7097837B2
(en)
*
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
EP1472337A4
(en)
|
2001-03-09 |
2008-02-27 |
Univ Texas |
INDUCTION OF TUMORIMMUNITY BY VARIATIONS OF THE FOLAT BINDING PROTEIN
|
|
WO2002072608A2
(en)
|
2001-03-09 |
2002-09-19 |
University Of Chicago |
POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
|
|
US8163289B2
(en)
*
|
2001-03-09 |
2012-04-24 |
Iterative Therapeutics, Inc. |
Methods and compositions involving polymeric immunoglobulin fusion proteins
|
|
SE0102327D0
(sv)
|
2001-06-28 |
2001-06-28 |
Active Biotech Ab |
A novel engineered superantigen for human therapy
|
|
MY144532A
(en)
*
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
|
KR20040009725A
(ko)
*
|
2002-07-25 |
2004-01-31 |
삼성전자주식회사 |
화상형성장치의 용지공급장치 및 그 제어방법
|
|
US7847084B2
(en)
|
2002-12-20 |
2010-12-07 |
Board Of Regents, The University Of Texas System |
VMP-like sequences of pathogenic Borrelia species and strains
|
|
US6900449B2
(en)
*
|
2003-01-15 |
2005-05-31 |
Lexmark International Inc. |
Media type sensing method for an imaging apparatus
|
|
WO2005035556A2
(en)
*
|
2003-05-06 |
2005-04-21 |
Iguazu Biosciences Corp. |
Sars-coronavirus virus-like particles and methods of use
|
|
CA2524623A1
(en)
|
2003-05-09 |
2004-11-18 |
Pharmexa A/S |
Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
|
|
US7910523B2
(en)
|
2003-05-23 |
2011-03-22 |
Board Of Regents, The University Of Texas System |
Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors
|
|
US7316907B2
(en)
|
2003-09-10 |
2008-01-08 |
Board Of Regents, The University Of Texas System |
14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types
|
|
US7205561B2
(en)
*
|
2004-03-29 |
2007-04-17 |
Lexmark International, Inc. |
Media sensor apparatus using a two component media sensor for media absence detection
|
|
US7627938B2
(en)
*
|
2004-10-15 |
2009-12-08 |
Board Of Regents, The Univeristy Of Texas System |
Tapered hollow metallic microneedle array assembly and method of making and using the same
|
|
EP1807157A2
(en)
|
2004-10-22 |
2007-07-18 |
Neurologix, Inc. |
Use of apoptosis inhibiting compounds in degenerative neurological disorders
|
|
US20060210590A1
(en)
|
2005-02-03 |
2006-09-21 |
Alk-Abello A/S |
Minor allergen control to increase safety of immunotherapy
|
|
CA2621083C
(en)
|
2005-08-30 |
2017-04-11 |
University Of Miami |
Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
|
|
ATE448247T1
(de)
|
2005-09-22 |
2009-11-15 |
Biocompatibles Uk Ltd |
Fusionspolypeptide vom glp-1 (glucagon-like peptide-1) mit erhöhten peptidaseresistenz
|
|
EP2368570A3
(en)
|
2006-01-18 |
2012-05-02 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
|
ATE444741T1
(de)
|
2006-05-10 |
2009-10-15 |
Biocompatibles Uk Ltd |
Glp-1 peptide enthaltende kugelförmige mikrokapseln, deren produktion und deren verwendung
|
|
KR101510082B1
(ko)
|
2006-08-01 |
2015-04-10 |
더 스크립스 리서치 인스티튜트 |
비만증을 억제하기 위한 백신 및 방법
|
|
US8652782B2
(en)
|
2006-09-12 |
2014-02-18 |
Longhorn Vaccines & Diagnostics, Llc |
Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
|
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
|
US8080645B2
(en)
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
|
DE102007039485A1
(de)
*
|
2007-08-21 |
2009-02-26 |
Manroland Ag |
Verfahren zum Betreiben einer Rollendruckmaschine
|
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
EP2772267B1
(en)
*
|
2007-08-27 |
2016-04-27 |
Longhorn Vaccines and Diagnostics, LLC |
Immunogenic compositions and methods
|
|
WO2009032978A2
(en)
*
|
2007-09-07 |
2009-03-12 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating urinary tract infections
|
|
AU2008343745B2
(en)
|
2007-10-01 |
2012-05-10 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection and transport system and methods of use
|
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
|
US9138470B2
(en)
*
|
2007-11-02 |
2015-09-22 |
The Johns Hopkins University |
Multi-component L2 vaccine for prevention of human papilloma virus infection
|
|
US8961991B2
(en)
*
|
2009-03-10 |
2015-02-24 |
Baylor Research Institute |
Anti-CD40 targeted fusion proteins
|
|
WO2010027818A2
(en)
|
2008-08-25 |
2010-03-11 |
Dana-Farber Cancer Institute, Inc. |
Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use
|
|
EP2163243A1
(en)
|
2008-09-12 |
2010-03-17 |
Biocompatibles UK Limited |
Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof
|
|
AU2009302582A1
(en)
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial Eap, Emp, and/or AdsA proteins
|
|
AU2010222942B2
(en)
*
|
2009-03-10 |
2013-01-10 |
Baylor Research Institute |
Anti-CD40 antibodies and uses thereof
|
|
CN103415534A
(zh)
|
2009-03-10 |
2013-11-27 |
贝勒研究院 |
靶向抗原呈递细胞的癌症疫苗
|
|
SI3281947T1
(sl)
|
2009-04-03 |
2020-07-31 |
The University Of Chicago |
Sestave in metode v zvezi z variantami proteina A (SPA)
|
|
EP2251028A1
(en)
|
2009-05-12 |
2010-11-17 |
Biocompatibles Uk Ltd. |
Treatment of eye diseases using encapsulated cells encoding and secreting an anti-angiogenic factor and/or a neuroprotective factor
|
|
BR112012000032A2
(pt)
|
2009-07-03 |
2016-03-15 |
Bionor Immuno As |
meios terapêuticos e diagnósticos inovadores
|
|
US9849174B2
(en)
|
2009-11-20 |
2017-12-26 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to immunogenic fibrils
|
|
WO2011063264A1
(en)
|
2009-11-20 |
2011-05-26 |
University Of Chicago |
Methods and compositions related to immunogenic fibrils
|
|
GB0922209D0
(en)
|
2009-12-18 |
2010-02-03 |
Univ Nottingham |
Proteins, nucleic acid molecules and compositions
|
|
US8476227B2
(en)
|
2010-01-22 |
2013-07-02 |
Ethicon Endo-Surgery, Inc. |
Methods of activating a melanocortin-4 receptor pathway in obese subjects
|
|
US9044606B2
(en)
|
2010-01-22 |
2015-06-02 |
Ethicon Endo-Surgery, Inc. |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
|
US20110229512A1
(en)
*
|
2010-03-19 |
2011-09-22 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating urinary tract infections
|
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
|
|
CA2803298C
(en)
|
2010-07-02 |
2020-07-14 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
|
JP5793194B2
(ja)
|
2010-09-09 |
2015-10-14 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
感染防御ブドウ球菌抗原が関与する方法および組成物
|
|
WO2012034704A1
(en)
|
2010-09-15 |
2012-03-22 |
Biocompatibles Uk Ltd. |
Treatment of vascular diseases using encapsulated cells encoding and secreting glp-1, or a fragment or variant thereof
|
|
US9381219B2
(en)
|
2010-12-29 |
2016-07-05 |
Ethicon Endo-Surgery, Inc. |
Brown adipocyte modification
|
|
EP2688592A4
(en)
|
2011-03-25 |
2015-07-22 |
Baylor Res Inst |
Compositions and methods for immunization against the hepatitis C virus
|
|
AU2012249264B2
(en)
|
2011-04-29 |
2017-08-10 |
Baylor College Of Medicine |
Ureaplasma vaccine and anitibody for prevention and treatment of human, animal and cell culture infection
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
CA3207612A1
(en)
|
2012-01-26 |
2013-08-01 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
WO2013162746A1
(en)
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
|
EP2858667A1
(en)
|
2012-06-06 |
2015-04-15 |
Bionor Immuno AS |
Hiv vaccine
|
|
WO2015007337A1
(en)
|
2013-07-19 |
2015-01-22 |
Bionor Immuno As |
Method for the vaccination against hiv
|
|
CN120939216A
(zh)
|
2014-01-13 |
2025-11-14 |
贝勒研究院 |
抗hpv和hpv相关的疾病的新疫苗
|
|
EP4154908A1
(en)
|
2014-03-10 |
2023-03-29 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for treating, including preventing, parvovirus infections and related diseases
|
|
CA2951616A1
(en)
|
2014-07-11 |
2016-01-14 |
Bionor Immuno As |
Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)
|
|
US10092738B2
(en)
|
2014-12-29 |
2018-10-09 |
Ethicon Llc |
Methods and devices for inhibiting nerves when activating brown adipose tissue
|
|
US10080884B2
(en)
|
2014-12-29 |
2018-09-25 |
Ethicon Llc |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US20180140694A1
(en)
|
2015-05-04 |
2018-05-24 |
Bionor Immuno As |
Dosage regimen for hiv vaccine
|
|
WO2016183292A1
(en)
|
2015-05-14 |
2016-11-17 |
Longhorn Vaccines And Diagnostics, Llc |
Rapid methods for the extraction of nucleic acids from biological samples
|
|
US11246924B2
(en)
|
2016-04-01 |
2022-02-15 |
Duke University |
Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
|
|
US10610585B2
(en)
|
2017-09-26 |
2020-04-07 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions for treating and preventing HIV
|
|
US11413336B2
(en)
|
2018-03-23 |
2022-08-16 |
Board Of Regents, The University Of Texas System |
Coccidioides antigens and methods of their use
|
|
TW202327646A
(zh)
|
2021-10-15 |
2023-07-16 |
美商輝瑞大藥廠 |
Rna分子
|
|
PE20241621A1
(es)
|
2021-12-17 |
2024-08-07 |
Pfizer |
Composiciones de polinucleotidos y sus usos
|
|
WO2023144779A1
(en)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Coronavirus antigen variants
|
|
TWI888970B
(zh)
|
2022-10-27 |
2025-07-01 |
美商輝瑞大藥廠 |
Rna分子
|
|
WO2024089634A1
(en)
|
2022-10-27 |
2024-05-02 |
Pfizer Inc. |
Immunogenic compositions against influenza and rsv
|
|
WO2024127181A1
(en)
|
2022-12-11 |
2024-06-20 |
Pfizer Inc. |
Immunogenic compositions against influenza and rsv
|
|
WO2024154052A1
(en)
|
2023-01-16 |
2024-07-25 |
Pfizer Inc. |
Immunogenic compositions and methods of inducing an immune response against varicella zoster virus
|
|
WO2024256962A1
(en)
|
2023-06-14 |
2024-12-19 |
Pfizer Inc. |
Method for stabilizing rna
|
|
WO2025027492A1
(en)
|
2023-07-31 |
2025-02-06 |
Pfizer Inc. |
Coronavirus antigen variants
|
|
WO2025126019A1
(en)
|
2023-12-13 |
2025-06-19 |
Pfizer Inc. |
Rna molecules
|
|
WO2025126071A1
(en)
|
2023-12-14 |
2025-06-19 |
Pfizer Inc. |
Rna molecules
|
|
WO2025186725A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Improved lnp formulations and uses thereof
|
|
WO2025186719A1
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
WO2025202834A1
(en)
|
2024-03-26 |
2025-10-02 |
Pfizer Inc. |
Polynucleotide compositions and uses thereof
|